The World Health Organization says it had temporarily suspended clinical trials of hydroxychloroquine, as a potential treatment for Covid-19 being carried out across a range of countries, as a precautionary measure.
The decision came after publication last week of a study in The Lancet which indicated that using the drug on Covid-19 patients could increase their chances of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference.
Tedros said that the executive group of the so-called Solidarity Trial, in which hundreds of hospitals across several countries have enrolled patients to test several possible treatments for the coronavirus, had as a precaution suspended trials using that drug. "The Executive Group has